Filing metadata

Accession number
0000950170-25-041429
Form type
Form 3
Filer
Kalaris Therapeutics, Inc.
CIK
CIK 1754068
Filed
Mar 18, 2025
Reporting period
Mar 18, 2025
Description
Initial ownership

Explore SEC Filings Hub